Details for 2022176524

Up to date per 02.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE FORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2022176524

EP Publication Number

4070787

E-Number

1550521

Language

PCT Number

Publication Date

12.10.2022 A

01.03.2023 B1

Registration Date

01.03.2023

AT Publication Date

15.03.2023

Application Date

29.06.2016

Registration Number

Priorities

30.06.2015

201562187113 P

22.02.2016

201662298373 P

29.02.2016

201662301429 P

01.04.2016

201662317286 P

IPC

A61K 9/20 20060101AFI20220823BHEP

Maximum Duration of Protection

29.06.2036

Owner

Gilead Sciences, Inc.333 Lakeside Drive Foster City, CA 94404US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

KOZIARA, Joanna, M. Foster City, 94404US

MCCALLISTER, Scott Foster City, 94404US

Information about Fees